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Enterohemorrhagic Escherichia coli (EHEC) strains comprise a broad group of bacteria, some of which cause
attaching and effacing (AE) lesions and enteritis in humans and animals. Non-O157:H7 EHEC strains contain
the gene efa-1 (referred to in previous publications as efa1), which influences adherence to cultured epithelial
cells. An almost identical gene in enteropathogenic E. coli (lifA) mediates the inhibition of lymphocyte
proliferation and proinflammatory cytokine synthesis. We have shown previously that significantly lower
numbers of EHEC O5 and O111 efa-1 mutants are shed in feces following experimental infection in calves and
that these mutants exhibit reduced adherence to intestinal epithelia compared with isogenic wild-type strains.
E. coli O157:H7 strains lack efa-1 but encode a homolog on the pO157 plasmid (toxB/l7095) and contain a
truncated version of the efa-1 gene (efa-1/z4332 in O island 122 of the EDL933 chromosome). Here we report
that E. coli O157:H7 toxB and efa-1 single and double mutants exhibit reduced adherence to cultured epithelial
cells and show reduced expression and secretion of proteins encoded by the locus of enterocyte effacement
(LEE), which plays a key role in the host-cell interactions of EHEC. The activity of LEE1, LEE4, and LEE5
promoters was not significantly altered in E. coli O157:H7 strains harboring toxB or efa-1 mutations, indi-
cating that the effect on the expression of LEE-encoded secreted proteins occurs at a posttranscriptional level.
Despite affecting type III secretion, mutation of toxB and efa-1 did not significantly affect the course of fecal
shedding of E. coli O157:H7 following experimental inoculation of 10- to 14-day-old calves or 6-week-old sheep.
Mutation of tir caused a significant reduction in fecal shedding of E. coli O157:H7 in calves, indicating that the
formation of AE lesions is important for colonization of the bovine intestine.
Enterohemorrhagic Escherichia coli (EHEC) strains are
zoonotic enteric pathogens of worldwide importance (39). In
humans, infection by some EHEC serotypes may cause diar-
rhea, which may be complicated by hemorrhagic colitis and
severe systemic sequelae, including hemolytic-uremic syn-
drome (45). EHEC strains are closely related to enteropatho-
genic E. coli (EPEC) strains, which are a leading cause of
infantile diarrhea in developing countries, and have many of
the EPEC genes implicated in virulence (13, 51).
Ruminants are an important reservoir of EHEC (15, 44),
and direct or indirect contact with ruminant feces is the leading
antecedent to EHEC infection in humans (17, 30, 43). Natural
and experimental infections of calves or sheep with EHEC
result in efficient colonization of the intestinal tract, and large
numbers of bacteria are shed in the feces for several weeks (3,
5–9, 18, 59, 67, 68). Strategies to reduce the prevalence of
EHEC in ruminants offer the potential to lower the incidence
of human infections (58). However, little is currently known
about the mechanisms underlying intestinal colonization of
cattle and sheep by EHEC.
EHEC strains are defined by their ability to produce one or
more Shiga toxins and to induce characteristic attaching and
effacing (AE) lesions on intestinal epithelia, in which the bac-
teria adhere intimately to the apical surface of enterocytes on
raised actin-rich pedestals and microvilli are locally destroyed.
This histopathology is determined by the chromosomal locus
of enterocyte effacement (LEE), which encodes a type III
protein secretion system (13). One of the LEE-encoded se-
creted proteins (Tir) is translocated into the host cell plasma
membrane, where it acts as a receptor for the bacterial outer
membrane protein intimin (10). Intimin is an important colo-
nization factor for E. coli O157:H7 in neonatal calves (7),
lambs (67), and adult cattle and sheep (5). Intimin can also
bind to 1-integrins (14) and cell surface-localized nucleolin
(57); however, the importance of such interactions and of type
III secretion in colonization of the ruminant intestine is un-
clear. Immunization of calves with E. coli O157:H7 type III
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secreted proteins reduces fecal shedding of the bacteria fol-
lowing experimental infection; however, the contribution of
individual secreted proteins in colonization and immunity in
ruminants requires detailed investigation (50).
Recently, it was reported that the product of the efa-1 gene
(EHEC factor for adherence; referred to in previous publica-
tions as efa1) influences intestinal colonization in calves by
non-O157:H7 EHEC (59). Efa1 was first identified as a factor
influencing adhesion of a clinical O111:H EHEC strain to
cultured epithelial cells (42). EHEC O5 and O111 strains har-
boring mutations in the efa-1 gene were shed in the feces in
significantly lower numbers than the corresponding parent
strains following oral inoculation of conventional calves. Fur-
thermore, an EHEC O111:H efa-1 mutant was impaired in
the ability to adhere to the colonic epithelium in calves, as
determined by confocal microscopy and direct recovery of bac-
teria from the mucosa (59).
The mechanism by which Efa1 influences intestinal coloni-
zation remains obscure. Mutation of efa-1 in EHEC O5 and
O111 reduces the expression and secretion of LEE-encoded
effector proteins, suggesting that it may indirectly influence
colonization (59). The EHEC O111:H Efa1 protein is 97.4%
identical at the amino acid level to EPEC lymphostatin (LifA),
which confers an ability to inhibit lymphocyte proliferation of
human peripheral blood lymphocytes and the mitogen-acti-
vated synthesis of proinflammatory cytokines (25). LifA also
inhibits the proliferation of human and murine intraepithelial
lymphocytes, indicating that LifA and Efa1 may influence in-
testinal colonization by modulating mucosal immunity in the
gut (21, 25–27, 32).
The efa-1/lifA gene is present in all non-O157:H7 EHEC
serotypes tested so far and in related enteropathogens, such as
Citrobacter rodentium and rabbit EPEC (REPEC) (25, 42, 60).
Sorbitol-fermenting E. coli O157:H strains also contain efa-1;
however, the intact efa-1 gene is absent from the E. coli
O157:H7 strains that have been sequenced (19, 22, 47). The
efa-1 gene in REPEC was recently shown to mediate bacterial
adherence to cultured epithelial cells, apparently without af-
fecting the secretion of LEE-encoded proteins, implying that it
may act as an adhesin in its own right (2). While E. coli
O157:H7 lacks the full-length efa-1 gene, a truncated version of
efa-1 (efa-1) is present in the chromosome (z4332 and z4333 in
O island 122 of the EDL933 genome). An E. coli O157:H7
mutant carrying a transposon insertion upstream of efa-1 (G2-
B12) showed reduced adherence to human colon carcinoma
cells (62; I. Tatsuno, personal communication), indicating that
the truncated Efa1 protein may have some of the properties of
full-length Efa1. Recent surveys of the prevalence of O island
122 revealed that it is frequently associated with EHEC iso-
lates from serious and/or epidemic disease, and the authors
speculated that the truncated efa-1 gene may contribute to
virulence (24, 38).
In addition to the product of the truncated efa-1 gene, E. coli
O157:H7 also encodes a large predicted protein (ToxB/L7095)
that exhibits 28% amino acid identity to Efa1 on the pO157
large plasmid (4, 31). E. coli O157:H7 strains containing de-
rivatives of pO157 that lack toxB exhibit reduced adherence to
cultured epithelial cells, possibly as a result of reduced expres-
sion and secretion of LEE-encoded type III secreted proteins
(63). The toxB gene has also been suggested to be a functional
homolog of EPEC lymphostatin, since an E. coli O157:H7
strain with pO157 deleted lacked the ability to inhibit interleu-
kin-2 and interleukin-4 synthesis in mitogen-activated human
peripheral blood lymphocytes (25). However, pO157 encodes
other secreted cytotoxins, including enterohemolysin (EhxA),
a serine protease (EspP), and a metalloprotease (StcE), and it
is unclear if ToxB alone mediates the inhibitory effect.
In order to clarify the role of the E. coli O157:H7 toxB and
truncated efa-1 genes, we investigated the effect of single and
combined defined mutations on the transcription and transla-
tion of LEE genes and intestinal colonization in calves and
sheep.
MATERIALS AND METHODS
Bacterial strains, plasmids, and media. E. coli O157:H7 strain 85-170 is a
spontaneous stx1- and stx2-negative derivative of strain 84-289 (65). 85-170 Nalr
is a spontaneous nalidixic acid-resistant derivative of 85-170 that was selected by
plating ca. 109 CFU of 85-170 on Luria-Bertani (LB) agar containing 25 g of
nalidixic acid per ml, followed by overnight incubation at 37°C. 85-170 Nalr
exhibits normal growth and adhesion characteristics in vitro. Plasmids pCVD442
(11) and pDM4 (37) are positive-selection suicide vectors containing a pir-
dependent R6K origin of replication, the mob region from plasmid RP4, and the
Bacillus subtilis sacBR genes and confer resistance to ampicillin and chloram-
phenicol, respectively. pCVD442, pDM4, and derivatives of these plasmids were
maintained in E. coli DH5 pir (49) and in E. coli S17-1pir for conjugation
(56). Plasmids pAJR71 and pAJR74 have been described previously (52) and
contain fusions of the LEE1 and LEE4 promoters, respectively, to a promoter-
less gene encoding an extended-half-life green fluorescent protein (eGFP). Plas-
mid pAJR70 (52) has single BamHI and KpnI sites 5 of a promoterless copy of
the gene encoding eGFP and was used to create an LEE5 reporter construct.
Bacteria were isolated on LB agar and were cultivated in LB broth with appro-
priate antibiotics at the following concentrations: ampicillin, 100 g/ml; chlor-
amphenicol, 25 g/ml; and nalidixic acid, 25 g/ml. For oral inoculation studies
bacteria were amplified in brain heart infusion broth for 18 h at 37°C, and the
absorbance at 600 nm was adjusted to within 0.05 U.
Cell lines. HeLa cells (ATCC CCL2) were cultivated in RPMI 1640 buffered
with 2 g of sodium bicarbonate per liter and supplemented with 10% (vol/vol)
fetal calf serum (PAA Laboratories GmbH, Haidmannweg, Austria) and 0.3 g of
L-glutamine per liter. For adhesion assays and fluorescent actin staining, cells
were seeded at a concentration of 2  105 cells/35-mm dish on glass coverslips
and grown for 18 h at 37°C in a humidified 5% CO2 atmosphere.
Routine DNA manipulation. Standard procedures were used for DNA extrac-
tion, cloning, PCR, and verification of mutants by Southern hybridization (54).
Construction of defined E. coli O157:H7 mutants. A deletion of the entire toxB
gene was created by overlapping PCR followed by allelic exchange with the
positive-selection suicide vector pCVD442. Sequences flanking the E. coli
O157:H7 toxB gene were separately amplified by PCR with Vent proofreading
DNA polymerase (New England Biolabs, Beverly, Mass.) by using the primer
pairs tox1 (5 ATATATGTCGACCGCCACAAAATGGCCG 3)-tox2 (5 GGA
AATCAGCGCTACATATCTATACCCTC 3) and tox3 (5 GGGTATAGATA
TGTAGCGCTGATTTCCTG 3)-tox4 (5 ATATATGTCGACGAGAGCATG
TGCTGGC 3) (based on the pO157 sequence; accession number AF074613).
The primary PCR products were gel purified and combined in an overlapping
PCR (20) by using the flanking primers tox1 and tox4. The secondary PCR
product was then cloned into pCVD442 via SalI sites incorporated into the
primers. The resulting plasmid, pCVD	toxB, was introduced into 85-170 Nalr by
conjugation from E. coli S17-1pir, and merodiploids were isolated on LB agar
containing ampicillin and nalidixic acid. Double recombinants were selected by
growing merodiploids to the late logarithmic phase in LB medium lacking am-
picillin and plating onto LB agar (without NaCl) containing 6% (wt/vol) sucrose
at 30°C. Sucrose-resistant colonies were screened for deletions by colony PCR,
and recombinants were verified by Southern hybridization. The deletion resulted
in juxtaposition of the predicted start and stop codons of toxB.
To create a deletion of the E. coli O157:H7 truncated efa-1 gene, sequences
flanking the gene were separately amplified by PCR with Vent DNA polymerase
by using the primer pairs efa-10 (5 ATATATGAGCTCGATGGTCAGGTC
GCAG 3)–efa-11 (5 GGCAGGATAGTTCAATTACATTTCCGCTTAAA 3)
and efa-12 (5GGAAATGTAATTGAACTATCCTGCCGCC 3)–efa-13 (5 AT
ATATGAGCTCCTTAGTTCCCTGTAAGCC 3) (based on the E. coli
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O157:H7 EDL933 sequence; accession number AE005174). The primary PCR
products were gel purified and combined in an overlapping PCR by using the
flanking primers efa-10 and efa-13. The secondary PCR product was then cloned
into pDM4 via SacI sites incorporated into the primers. The resulting plasmid,
pDM4efa-11013, was introduced into 85-170 Nalr and 85-170 Nalr 	toxB by
conjugation from E. coli S17-1pir, and merodiploids were isolated on LB agar
containing chloramphenicol and nalidixic acid. Double recombinants were se-
lected essentially as described above, and they were screened for the efa-1
deletion by colony PCR and verified by Southern hybridization. The deletion
removed the open reading frame encoding the N-terminal 433 amino acids of
Efa1 and also removed the start codon and N-terminal 97 amino acids of a
contiguous 3 open reading frame encoding a predicted 275-amino-acid protein
that was 100% identical to amino acids 435 to 710 of Efa1.
A tir deletion mutant of strain 85-170 Nalr was used as a control in calf
infection studies and was constructed as follows. Sequences flanking the tir gene
were separately amplified by using the primer pairs tir1 (5 ATATATGAGCTC
TAGCATCATCGAGAGGG 3)-tir2 (5 CCTATTGGTAATCTTGGATCCCA
TCGTTTCGTC 3) and tir3 (5 GAAACGATGGGATCCAAGATTACCAAT
AGGCAT 3)-tir4 (5 ATATATGAGCTCGGGATAACCTTGTCAGG 3).
The primary PCR products were gel purified and combined in an overlapping
PCR by using the flanking primers tir1 and tir4. The secondary PCR product was
then cloned into pDM4 via SacI sites incorporated into the primers, and the
resulting plasmid, pDM4	tir, was introduced into 85-170 Nalr by conjugation
from E. coli S17-1pir. A double recombinant was selected as described above.
The in-frame deletion resulted in juxtaposition of the first and last six codons of
the tir gene. The 85-170 Nalr 	tir mutant strain expressed normal levels of
intimin, as assessed by Western blotting (data not shown), indicating that the
deletion was nonpolar.
Adhesion and fluorescent actin staining assays. Adhesion of EHEC strains to
HeLa cells was quantified by visual observation essentially as described previ-
ously (16, 63). Semiconfluent HeLa cells grown on 22-mm glass coverslips were
overlaid with serum-free RPMI 1640 buffered with 2 g of sodium bicarbonate per
liter and were inoculated at a multiplicity of infection of approximately 50:1 with
fresh stationary-phase LB medium cultures of 85-170 Nalr wild-type and mutant
strains adjusted to the same optical density. Cells were incubated for 3 h at 37°C
in a humidified 5% CO2 atmosphere, washed three times with 2 ml of phosphate-
buffered saline (PBS), and then incubated in fresh medium for an additional 3 h.
Cells were washed five times with 2 ml of PBS, fixed, and stained with Hemacolor
rapid staining solutions (Merck, Darmstadt, Germany), and multiple images
were captured at a magnification of 400 by using a Leica DMLS microscope
with a Polaroid digital microscope camera. For each independent assay 20
randomly selected fields containing 50 or more cells were examined, and the
mean number of microcolonies (MC) (comprising eight or more bacteria) per
cell was determined. Assays were performed three times, and the microscopic
observations were made by a researcher unfamiliar with the identities of the
strains tested. The results are given below as the mean number of MC per cell (

standard deviation) from three independent experiments.
Fluorescent actin staining for the detection of filamentous actin under sites of
bacterial adhesion to HeLa cells was performed as described previously (28),
except that bacteria were incubated on the cells for a total of 8 h.
Detection of EspD by Western blotting. To measure expression and secretion
of the LEE-encoded type III secreted protein EspD, bacteria were grown to the
late logarithmic phase (A600, ca. 1.0) in minimal essential medium buffered with
25 mM HEPES (MEM-HEPES). Secreted proteins were precipitated with tri-
chloroacetic acid as described previously (35), and total protein was prepared
from 1 ml of each culture by centrifugation and resuspension in sodium dodecyl
sulfate-polyacrylamide gel electrophoresis sample buffer. Approximately 25 g
of whole-cell protein was analyzed by Western blotting by using a monoclonal
antibody specific for EspD and a horseradish peroxidase-conjugated goat anti-
mouse immunoglobulin secondary antibody (Dako, Cambridge, United King-
dom). Bound antibody was visualized after 5 min of incubation with a 1:1 mixture
of Pierce (Rockford, Ill.) luminol enhancer solution and Pierce stable peroxide
solution. Relative levels of EspD were determined by quantifying luminescence
with a Flowgen MultiImage cabinet and MultiImage Spot densitometer software
(Flowgen, Ashby de la Zouch, United Kingdom). Three independent experi-
ments were performed, and equivalent loading of proteins was verified by Coo-
massie blue staining of gels.
Detection of EspA filaments by immunofluorescence microscopy. To detect
EspA filaments, bacteria grown overnight in M9 minimal medium containing
0.2% (wt/vol) glucose were subcultured in MEM-HEPES. Since EspA filament
expression is growth phase dependent (52), cultures were sampled at A600 values
of 0.4, 0.8, and 1.0. Bacteria were fixed with 0.1% (wt/vol) paraformaldehyde for
5 min at room temperature, and a 20-l aliquot of each suspension was dried
onto a microscope slide at 37°C for 20 min. A 1:100 dilution of EspA antibody
(66) in PBS containing 0.1% bovine serum albumin was applied to the slide.
After incubation in a humid chamber with gentle rocking for 1 h, the slide was
washed three times with PBS containing 0.1% (wt/vol) bovine serum albumin,
and then a 1:500 dilution of fluorescein isothiocyanate-conjugated anti-rabbit
immunoglobulin secondary antibody was applied to the slide. After incubation
and washing as described above, the slides were examined by fluorescence mi-
croscopy by using appropriate filter sets, and the images were captured by using
Leica software. The number of bacteria stained with the EspA antibody was
expressed as a proportion of ca. 900 bacteria from three independent experi-
ments (three fields containing ca. 100 bacteria captured per time point per strain
in each of three experiments), essentially as described previously (52).
Measurement of LEE promoter activity by using green fluorescent protein
plasmid reporter constructs. Reporter constructs to quantify the activities of the
LEE1 and LEE4 promoters (pAJR71 and pAJR74) have been described previ-
ously (52). To create an LEE5 reporter construct, the LEE5 (tir) promoter was
amplified by PCR by using Lee5 5 BamHI (5 CGGGATCCCGCGATAAAG
AAACTTAATAAACT 3) and Lee5 3 KpnI (5 CGGGTACCTGAAGGTAA
TGGAGGTGCAGG 3) and was cloned into pAJR70 upstream of a promoter-
less copy of the gene encoding eGFP, yielding pAJR75. To measure the activities
of the LEE1, LEE4, and LEE5 promoters, plasmids pAJR71, pAJR74, and
pAJR75 were separately transformed into the 85-170 Nalr wild-type strain and
	toxB and 	efa-1 mutant strains by electroporation by using a Bio-Rad Gene
Pulser according to the manufacturer’s instructions. Transformants were grown
overnight in MEM-HEPES containing chloramphenicol and then subcultured
1:50 in fresh, prewarmed medium. The A600 of each of the cultures was moni-
tored by measurement with a spectrophotometer. At intervals, 200-l portions of
the cultures were removed, and the eGFP that had accumulated was quantified
by using a FLUOstar Optima fluorescence plate reader (BMG Labtechnologies
GmbH, Offenburg, Germany) at appropriate excitation and emission wave-
lengths. Control bacteria containing no plasmid were used to measure the back-
ground fluorescence.
Oral inoculation of calves. Fifteen 10- to-14-day-old Friesian bull calves were
used in this study. The calves were housed in a high-containment accommodation
in tanks on tenderfoot mats and were fed milk replacer twice daily, and they had
free access to water. Prior to infection the calves were confirmed to be culture
negative for EHEC and Salmonella by direct plating of rectal swabs on sorbitol
MacConkey agar containing 2.5 g of potassium tellurite (T-SMAC) per ml and
brilliant green agar (Oxoid, Basingstoke, United Kingdom), respectively. While
is it acknowledged that T-SMAC may not detect all EHEC, this medium is highly
selective for serogroups O157 and O26, which are by far the most prevalent
serogroups in cattle in the United Kingdom at present. Presumptive EHEC
colonies were screened for stx1 and stx2 genes by PCR by using the primer pairs
Stx1F (5 ATAAATCGCCATTCGTTGACTAC 3)-Stx1R (5 AGAACGCCC
ACTGAGATCATC 3) and Stx2F (5 GGCACTGTCTGAAACTGCTCC 3)-
Stx2R (5 TCGCCAGTTATCTGACATTCTG 3). Animals excreting stx-posi-
tive E. coli were excluded from the study. All calves were obtained from the same
farm and received colostrum from their dams for the first 24 to 48 h. After this,
no further colostrum was given. Total serum immunoglobulin levels were mea-
sured when the calves were 1 or 2 days old as a measure of colostrum intake by
the zinc sulfate turbidity assay. Only calves with a zinc sulfate turbidity value of
more than 10 were used.
Calves were orally challenged with ca. 1  1010 CFU of EHEC in 20 ml of
antacid (5% [wt/vol] MgO, 5% [wt/vol] Mg trisilicate, and 5% [wt/vol] NaHCO3
in double-distilled water) just before the morning feeding. Mutants 85-170 Nalr
	toxB, 85-170 Nalr 	efa-1, and 85-170 Nalr 	toxB 	efa-1 were each adminis-
tered to two calves. The parent strain, 85-170 Nalr, was administered to a total of
five calves. An 85-170 Nalr 	tir mutant was administered to four calves. During
the next 7 days, the calves were observed for clinical signs, and fecal samples were
taken twice daily by rectal palpation. The numbers of viable EHEC per gram of
feces were determined by plating triplicate 10-fold serial dilutions onto sorbitol
MacConkey agar containing 20 g of nalidixic acid per ml and 2.5 g of potas-
sium tellurite per ml (lower limit of detection, 100 CFU/g).
Oral inoculation of sheep. Eighteen 6-week-old cross-bred lambs were ran-
domly divided into two equal groups and supplied with food and water ad
libitum, and they were confirmed to be free of EHEC by enrichment culturing as
described previously (67). Nine lambs were dosed orally by gavage with 1  109
CFU of 85-170 Nalr resuspended in 10 ml of PBS, and a separate group of nine
lambs was given a matching dose of 85-170 Nalr 	toxB 	efa-1. Approximately
24 h after administration of the bacteria and as required thereafter for up to 24
days, rectal fecal samples were collected from each group and used for direct
plating onto sorbitol MacConkey plates supplemented with 20 g of nalidixic
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acid per ml. One lamb from each group was sacrificed on days 3, 8 and 18
postinfection for bacteriological and histological analyses of tissues.
All animal experiments were performed in accordance with the Animals (Sci-
entific Procedures) Act 1986 and were approved by the local ethical review
committee. The fecal shedding data were statistically analyzed for the effect of
mutation by using an F test, with the data taken as repeated measurements (Proc
Mixed Statistical Analysis System, 1995; SAS Institute, Cary, N.C.). P values of
0.05 were considered significant.
RESULTS
Mutation of the E. coli O157:H7 toxB and truncated efa-1
genes influences bacterial adherence to cultured HeLa cells
but not filamentous actin nucleation. Quantitative adherence
assays were performed by using HeLa cells, the 85-170 Nalr
	toxB and 	efa-1 single and double mutants, and the parent
strain. Mutation of the E. coli O157:H7 toxB and efa-1 genes
did not alter the in vitro growth rates of the mutants compared
to those of the parent strain (data not shown). The numbers of
MC comprising eight or more bacteria per HeLa cell in three
independent experiments were as follows: for 85-170 Nalr,
0.0784 
 0.0162 MC/cell; for 85-170 Nalr 	toxB, 0.0192 

0.0228 MC/cell; for 85-170 Nalr 	efa-1, 0.0216 
 0.0250 MC/
cell; and for 85-170 Nalr 	toxB 	efa-1, 0.0066 
 0.0078 MC/
cell (means 
 standard deviations). Thus, mutation of toxB or
efa-1 alone caused a ca. fourfold reduction in MC formation
(for toxB, P  0.006; for efa-1, P  0.007). These phenotypes
are comparable to those reported by Tatsuno et al. (62, 63). A
double mutant lacking both toxB and efa-1 exhibited a ca.
12-fold reduction in MC formation compared to the wild-type
strain (P  0.002). Despite forming fewer MC, the mutant
strains still nucleated filamentous actin under the sites of at-
tachment to HeLa cells (Fig. 1), indicating that LEE-mediated
rearrangement of cytoskeletal actin could still occur.
We are aware that unintended secondary mutations can
result from allelic exchange when positive-selection suicide
vectors are used (23), and therefore we attempted to trans-
complement the defects in MC formation by cloning and ex-
pression of the toxB and efa-1 genes. Several unsuccessful
attempts were made to subclone toxB on a ca. 10-kb AatII
fragment from pO157 into the low-copy-number vector
pACYC184. We obtained the mini-pO157 derivative contain-
ing toxB described by Tatsuno et al. (63) (pIC37, kindly sup-
plied by C. Sasakawa, University of Tokyo). However, this
plasmid could not be stably maintained in 85-170 Nalr 	toxB.
When kanamycin-resistant bacteria containing pIC37 were ob-
tained, they exhibited an extremely low growth rate in vitro
(data not shown), which prohibited the development of MC in
the adherence assay.
Badea et al. recently reported that they were unable to clone
the N-terminal 376 amino acids of REPEC efa-1 (2), presum-
ably because of toxicity. We were successful in cloning the
truncated efa-1 gene from E. coli O157:H7 (z4332) together
with the contiguous open reading frame z4333 in pET30-Ek/
Lic (Novagen, Madison, Wis.). However, induction of expres-
sion of efa-1 caused a dramatic decrease in the growth rate,
making quantification of MC formation unreliable (data not
shown).
Mutation of the E. coli O157:H7 toxB and truncated efa-1
genes reduces expression and secretion of LEE4-encoded pro-
teins. Expression and secretion of the LEE4-encoded type III
secreted protein EspD by the E. coli O157:H7 wild-type strain
and 	toxB, 	efa-1, and 	toxB 	efa-1 mutant strains were
analyzed by Western blotting by using specific antiserum (Fig.
2). The densities of secreted EspD based on three independent
experiments were as follows: for 85-170 Nalr, 1,664 
 108; for
85-170 Nalr 	toxB, 792 
 123; for 85-170 Nalr 	efa-1, 1,638 

196; and for 85-170 Nalr 	toxB 	efa-1, 201 
 87 (means 

standard deviations). Thus, mutation of toxB caused a signifi-
FIG. 1. Nucleation of filamentous actin under sites of adherence of the 85-170 Nalr wild-type strain and 	toxB and 	efa-1 single and double
mutant strains to cultured HeLa cells. Cells were examined by fluorescent actin staining by using Oregon Green 514-phalloidin (green) and a
confocal laser scanning microscope. Bacteria were detected with rabbit anti-O157 lipopolysaccharide typing serum and anti-rabbit Ig-Alexa568
(red). (A) 85-170 Nalr; (B) 85-170 Nalr 	toxB; (C) 85-170 Nalr 	efa-1; (D) 85-170 Nalr 	toxB 	efa-1. Representative images are shown.
Magnification, 630.
FIG. 2. Effects of toxB and efa-1 mutations on expression and
secretion of the LEE4-encoded type III secreted protein EspD.
Whole-cell and secreted protein fractions of 85-170 Nalr, 85-170 Nalr
	toxB, 85-170 Nalr 	efa-1, and 85-170 Nalr 	toxB 	efa-1 (ca. 25 g of
protein) were resolved by sodium dodecyl sulfate–15% polyacrylamide
gel electrophoresis. Proteins were transferred to nitrocellulose mem-
branes and probed by using a mouse monoclonal antibody specific for
EspD. Equivalent loading of proteins was confirmed by Coomassie
blue staining of gels (data not shown). WT, wild type.
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cant reduction in the secretion of EspD (the value was 2.1-fold
lower than the wild-type value; P  0.001). While mutation of
efa-1 alone had little effect (P  0.82), a cumulative reduction
in EspD expression occurred when both toxB and efa-1 were
deleted (the value was ca. 8.2-fold lower than the wild-type and
single efa-1 mutant values; P  0.001). Similar reductions in
the expression of EspD were detected following analysis of
whole-cell protein from the wild-type and mutant strains (Fig.
2).
We also analyzed the expression of EspA filaments by the
wild type and the 	toxB 	efa-1 mutant strain by indirect im-
munofluorescence. It was observed previously that EspA fila-
ments are not produced during growth in M9 minimal medium
but are induced following subculture in MEM-HEPES (52).
Upon induction, not all bacteria in the population express
EspA filaments at a given time, and the highest proportion of
bacteria with EspA filaments is detected in the late exponential
phase (52). We determined the proportion of wild-type and
mutant bacteria elaborating EspA filaments at A600 values of
0.4, 0.8, and 1.0. Mutation of toxB and efa-1 singly or in
combination resulted in a reduction in the proportion of bac-
teria elaborating EspA filaments (Fig. 3); however, the differ-
ence was significant only for samples collected at an A600 of 0.4
(for 85-170 Nalr 	toxB, P  0.004; for 85-170 Nalr 	efa-1, P 
0.013; for 85-170 Nalr 	toxB 	efa-1, P  0.008). During the
late logarithmic phase (A600, 0.8 and 1.0), the extent of EspA
filamentation observed with the mutant strains was consistent
with the levels of EspD detected by Western blotting (Fig. 2).
Since the production of EspA filaments by EHEC is dependent
on EspD (29), it is not possible to state whether the observed
reduction in EspA filament production in the mutant strains
was the result of lower EspD production (Fig. 2), lower EspA
production, or a combination of the two.
Since production of LEE4-encoded proteins is growth phase
dependent (52, 53), it was not possible to trans-complement
the defects in EspD or EspA production owing to the inhibi-
tory effect of plasmids containing toxB or efa-1 on bacterial
growth (data not shown).
Mutation of the E. coli O157:H7 toxB and truncated efa-1
genes does not affect the activity of the LEE1, LEE4, and LEE5
promoters. To determine if mutation of toxB and efa-1 impairs
the production of EspD and EspA filaments by reducing the
transcription of LEE genes, we separately transformed a series
of plasmid-borne eGFP-reporter constructs into the wild-type
and mutant strains in order to measure the activity of the
LEE1 (ler), LEE4 (sepL), and LEE5 (tir) promoters (pAJR71,
pAJR74, and pAJR75, respectively). The emission of fluores-
cence due to accumulation of eGFP was quantified at several
points in the growth cycle. No significant differences in the
activities of the LEE1, LEE4, and LEE5 promoters were de-
tected in strains harboring the toxB and efa-1 mutations com-
pared to the parent strain (Fig. 4). Indeed, the activity of the
LEE4 promoter was slightly greater for the 85-170 Nalr 	toxB
and 	efa-1 mutant strains than for the parent strain. Thus,
mutation of toxB and efa-1 affects the expression of EspD at a
posttranscriptional level.
Mutation of the E. coli O157:H7 toxB and truncated efa-1
genes does not affect intestinal colonization in calves or sheep.
To investigate the role of the E. coli O157:H7 toxB and efa-1
genes in intestinal colonization, we first inoculated two 10- to
14-day-old conventional Friesian bull calves with E. coli 85-170
Nalr 	toxB, 85-170 Nalr 	efa-1, or 85-170 Nalr 	toxB 	efa-1
by the oral route. Colony PCRs were performed on days 1 and
7 postinoculation by using a minimum of 10 independent na-
lidixic-acid resistant isolates from each calf, and this analysis
confirmed that only the inoculum strain was shed (data not
shown). The stx-negative 85-170 Nalr parent strain was admin-
istered to five calves and was shed at levels of 105 CFU/g of
feces for the duration of the experiment. No significant differ-
ences in the shedding patterns were detected between the
wild-type and mutant strains (P values at 7 days postinocula-
tion: for 	toxB, 0.83; for 	efa-1, 0.10; and for 	toxB 	efa-1,
0.9) (Fig. 5). As a control, four calves were inoculated with an
85-170 Nalr mutant harboring an in-frame nonpolar deletion in
the tir gene. By day 7 postinoculation the 85-170 Nalr 	tir
mutant was shed at significantly lower numbers than the wild
type (P  0.004). Indeed, the reduction in shedding of the tir
mutant reached significance at just 3 days postinoculation (P
0.018).
We separately assessed the ability of the 85-170 Nalr 	toxB
	efa-1 mutant to colonize the ovine intestine by orally inoc-
ulating groups of nine 6-week-old sheep with the wild-type or
double mutant strain, and fecal shedding was quantified for up
to 24 days. This model was recently used to establish a role for
intimin in persistent colonization of the ovine intestine (67).
No significant differences in the shedding patterns were de-
tected between the wild-type and mutant strains at any time
tested (Fig. 6).
DISCUSSION
It has been reported previously that mutation of the efa-1
gene of EHEC serotypes O5 and O111 results in a significant
reduction in fecal shedding of the organisms (P  0.05 at 7
days postinoculation) (52). E. coli O157:H7 strains lack the
full-length efa-1 gene; however, a truncated version of efa-1 is
FIG. 3. Effect of mutation of toxB and efa-1 on the formation of
EspA filaments. EspA filaments were visualized by indirect immuno-
fluorescence following subculture of bacteria grown in M9 minimal
medium into MEM-HEPES. Samples were prepared at A600 values of
0.4, 0.8, and 1.0. The proportions of bacteria expressing EspA fila-
ments were determined as described in Materials and Methods, and
the data are the means 
 standard deviations for three independent
experiments. WT, wild type.
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present in the chromosome (19, 47), and a homolog of efa-1
(toxB/l7095) is present in the large plasmid (4, 31). To clarify
the role of these genes, we constructed single and double
	toxB and 	efa-1 mutants of E. coli O157:H7 and assessed
the phenotypes of the mutants in vitro and in calves and
sheep.
Consistent with the observations of Tatsuno et al. (63), we
found that deletion of the E. coli O157:H7 toxB gene led to a
reduction in the expression and secretion of LEE4-encoded
type III secreted proteins and impaired MC formation on
cultured epithelial cells. Furthermore, we found for the first
time that a defined mutation of the truncated version of efa-1
alone caused a reduction in MC formation on HeLa cells. This
is consistent with the finding that a transposon insertion up-
stream of efa-1 reduced adherence to Caco-2 cells to 25 to
50% of the wild-type adherence level (62; I. Tatsuno, personal
communication). The efa-1 single mutant expressed and se-
creted wild-type levels of EspD, and the production of EspA
filaments was not reduced significantly during the phase of
growth when such filaments are expressed maximally. This is in
accordance with the finding that the G2-B12 efa-1 mutant
FIG. 4. Effect of toxB and efa-1 mutations on the activity of LEE1,
LEE4, and LEE5 promoters. Plasmids pAJR71 (lee1::gfp), pAJR74
(lee4::gfp), and pAJR75 (lee5::gfp) were separately transformed into
85-170 Nalr, 85-170 Nalr 	toxB, 85-170 Nalr 	efa-1, and 85-170 Nalr
	toxB 	efa-1, and the bacteria were grown in MEM-HEPES. At
stages in the growth cycle the absorbance of the cultures was recorded,
and the fluorescence due to accumulation of eGFP was quantified. The
data are the means for two independent measurements. wt, wild type.
FIG. 5. Mutation of toxB and efa-1 does not significantly affect the
course of fecal shedding of E. coli O157:H7 in calves. The data are
fecal shedding data for duplicate calves inoculated with the 85-170 Nalr
	toxB, 85-170 Nalr 	efa-1, and 85-170 Nalr 	toxB 	efa-1 mutants.
Data from five calves infected with 85-170 Nalr and four calves infected
with 85-170 Nalr 	tir are shown for comparison. The bacterial recovery
from the feces was measured twice each day. The data are daily means

 standard errors of the means. wt, wild type.
FIG. 6. Mutation of both toxB and efa-1 does not significantly
affect the course of fecal shedding of E. coli O157:H7 in 6-week-old
sheep. Animals were inoculated with 85-170 Nalr or 85-170 Nalr 	toxB
	efa-1 (nine animals per group), and fecal samples were collected at
intervals up to 24 days. One lamb from each group was sacrificed on
days 3, 8, and 18 postinfection, and postmortem examinations were
performed. The data are means 
 standard deviations for different
times.
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identified by Tatsuno et al. produced wild-type levels of EspA
as assessed by immunoblotting (62). In contrast, deletion of
efa-1 in combination with toxB led to marked reductions in the
expression and secretion of EspD and EspA filament produc-
tion and a further reduction in the ability of the bacteria to
form MC on cultured cells, implying that there is a synergistic
effect. In all cases the reduction in EspD and EspA expression
and secretion was not sufficient to prevent the nucleation of
filamentous actin under the sites of E. coli O157:H7 attach-
ment to cultured cells (62, 63; this study). Some bacteria har-
boring the 	toxB 	efa-1 double mutation still assembled EspA
filaments on their surfaces, as detected by indirect immunoflu-
orescence. Since actin condensation under adherent bacteria is
dependent on the delivery of LEE-encoded type III secreted
effectors, our data indicate that sufficient quantities of LEE4-
encoded proteins are still produced and translocated into ep-
ithelial cells so that the bacteria can elicit cytoskeletal rear-
rangements.
We attempted to trans-complement the defects in MC for-
mation and the expression and secretion of EspD and EspA in
the mutant strains by cloning and expressing the toxB and
efa-1 genes. Several unsuccessful attempts were made to sub-
clone toxB from pO157, and it is likely that this gene is unstable
and/or toxic, as has been reported for the homologous 9.5-kb
efa-1 gene (22, 25, 42). A mini-pO157 derivative containing
toxB described by Tatsuno et al. (63) could not be stably main-
tained in 85-170 Nalr 	toxB, most likely as a result of incom-
patibility with the endogenous pO157	toxB plasmid. We were
able to clone the truncated efa-1 gene from E. coli O157:H7;
however, induction of gene expression restricted the growth
rate, probably as a consequence of toxicity, as reported else-
where (2).
Mutation of toxB caused a defect in the expression and
secretion of LEE-encoded type III secreted effectors whose
magnitude was similar to that seen in EHEC O5 and O111
efa-1 mutants (59). Type III secretion of EspD was impaired by
ca. eightfold in an E. coli O157:H7 mutant harboring deletions
of both toxB and efa-1. Despite this, no significant reduction in
fecal shedding of E. coli O157:H7 was seen in calves or sheep
infected with the mutant strains. Our data are consistent with
the observation that an E. coli O157:H7 strain with the pO157
plasmid which encodes toxB deleted colonizes gnotobiotic pig-
lets and induces enteritis at least as well as the wild type (65).
We cannot preclude the possibility that there were differences
in the immune status of the animals used in the present study
or the possibility that various levels of passively acquired
EHEC-specific maternal antibody masked subtle effects of the
mutations.
LEE-encoded type III secreted proteins are major virulence
factors for several AE pathogens in their target animal species,
including EPEC EspB in humans (61), REPEC EspA, EspB,
and Tir in rabbits (1, 33), and Citrobacter rodentium EspB in
mice (41). Data supporting a role for LEE-encoded type III
secreted proteins in the colonization of ruminants by E. coli
O157:H7 were recently provided by the finding that immuni-
zation of calves with E. coli O157:H7 type III secreted proteins
reduces fecal shedding of the bacteria upon subsequent chal-
lenge (50). Considerable natural variation in the level of se-
cretion of the LEE-encoded Tir and EspD proteins has been
observed among EHEC O157:H7 strains isolated from cattle
(35); however, it is not known if this correlates with the ability
of the strains to colonize the intestines efficiently. While the E.
coli O157:H7 	toxB 	efa-1 double mutant was impaired in the
ability to express and secrete LEE4-encoded proteins, the
amount of EspD secreted by this mutant was comparable to
the amounts secreted by naturally occurring E. coli O157:H7
strains isolated from cattle (35; Roe and Gally, unpublished
observations).
When the ability of E. coli O157:H7 to form AE lesions was
abolished through deletion of the tir gene, we observed a sig-
nificant reduction in fecal shedding of the bacteria following
oral inoculation of calves. This indicates that differences in the
ability of EHEC strains to colonize the bovine intestine can be
detected with our oral challenge model and that the model
does not merely measure shedding of the inoculum. Further-
more, it shows for the first time that the translocated intimin
receptor is required for intestinal colonization in calves. This
implies that the role of intimin in intestinal colonization of
calves and sheep may be explained, at least in part, by its ability
to bind to its translocated receptor instead of secondary recep-
tors, such as 1-integrins (14) and/or cell surface-localized
nucleolin (57). There is strong evidence for the existence of
host cell intimin receptors, and the role of such molecules in
the carriage and tissue tropism of EHEC merits close investi-
gation.
It is unclear why mutation of efa-1 in EHEC O5 and O111
impairs intestinal colonization in calves whereas mutation of
toxB in EHEC O157:H7 does not, even though type III secre-
tion is similarly affected in the two backgrounds. It is possible
that different EHEC serotypes rely to different extents on the
LEE-encoded type III secretion system for intestinal coloniza-
tion. There is increasing evidence that different EHEC sero-
vars colonize the intestines of calves by distinct mechanisms.
We and other workers have shown that EHEC serotypes O5,
O26, and O111 adhere extensively to the intestinal epithelium
in the bovine cecum, colon, and rectum and can readily be seen
forming AE lesions (46, 59). In contrast, E. coli O157:H7 is
rarely detected in association with the intestinal epithelium at
these sites following oral inoculation of calves even though
high numbers of organisms may be shed (6, 8, 68). E. coli
O157:H7 may exhibit a specific tropism for lymphoid follicle-
dense mucosa at the terminal rectum in weaned calves and
adult cattle (40); however, preliminary data from our labora-
tories have indicated that non-O157 EHEC serotypes do not
share a tropism for this site (S. W. Naylor, A. J. Roe, and D. L.
Gally, unpublished observations). It is not known if E. coli
O157:H7 exhibits a specific tropism for the terminal rectum in
animals that are the ages we used. Indeed, the preweaned
calves and 6-week-old lambs inoculated in this study had not
started to ruminate, and it is not clear if lymphoid follicle-
dense epithelium has even matured in the terminal rectum at
this age. The role of specific E. coli O157:H7 genes in coloni-
zation of the terminal rectum and other sites in preweaned,
weaned, and adult ruminants awaits detailed investigation.
It is possible that Efa1 influences intestinal colonization of
calves by EHEC O5 and O111 by acting independently of the
LEE. Given that Efa1 is 97.4% identical to EPEC lymphosta-
tin, this molecule may facilitate colonization by suppressing the
activation of gastrointestinal lymphocytes. However, in a re-
cent study it was not possible to detect lymphostatin-like effects
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on bovine intraepithelial lymphocytes exposed to EHEC sero-
type O103:H2 in situ in a ligated ileal loop model of infection
(36). It is also possible that Efa1 acts as an adhesin per se or
influences adhesion indirectly by some other mechanism. In-
deed, Badea et al. reported that Efa1 mediates adherence of
REPEC to cultured epithelial cells, apparently without affect-
ing the expression and secretion of LEE-encoded proteins (2).
Furthermore, Efa1-specific antibody inhibited the adherence
of REPEC to cultured cells (2). It may be that ToxB and the
truncated version of Efa1 do not influence intestinal coloniza-
tion by E. coli O157:H7 because they do not share the activities
of Efa1.
Our data and those of Tatsuno et al. (63) suggest that Efa1
and ToxB influence the expression of LEE-encoded type III
secreted proteins at a posttranscriptional level. Almost all
LEE-positive strains tested to date contain either Efa1 or
ToxB (25, 42, 60), and indeed in EHEC O26 strain 413/89-1
and REPEC strains RDEC-1 and 83/89, the LEE and efa-1 are
adjacent on the chromosome (64, 69) (EHEC O26 LEE ac-
cession number AJ277443). This close genetic linkage occurs
in many other EPEC and EHEC strains (38) and may imply
that Efa1 is required for complete activity of the LEE-encoded
type III secretion system. Furthermore, O island 122, which
contains truncated efa-1, is also significantly associated with
LEE-positive EHEC strains that cause serious and/or epidemic
disease (24, 38). No enzymatic activities have yet been ascribed
to the EHEC Efa1, Efa1, and ToxB proteins. Efa1 and ToxB
are highly homologous to large clostridial toxins at the N ter-
minus and share a DXD glycosyltransferase motif (4, 25, 31,
42), and both contain a cysteine protease motif that is present
in numerous other secreted bacterial virulence factors (55).
The 433-amino-acid truncated Efa1 protein lacks both these
motifs, and their relevance to the activities of Efa1 and ToxB
remains to be tested.
The mechanism by which Efa1 and ToxB influence the trans-
lation of LEE4 transcripts is unclear. For some type III secre-
tion systems in gram-negative bacteria, it has been suggested
that the secretion signal for translocated effector proteins is
present in the mRNA and that translation and secretion of the
proteins may be coupled at the needle complex (48). If such a
situation applied to the EHEC LEE-encoded type III secretion
apparatus, then it is conceivable that toxB and efa-1 mutations
may influence expression and secretion of LEE4-encoded pro-
teins by interfering with the proper insertion and assembly of
the type III secretion apparatus in the membrane and/or the
targeting of LEE transcripts.
Interestingly, LifA does not appear to be required for effi-
cient production and secretion of LEE-encoded effector pro-
teins in human or REPEC strains (2, 59). It is noteworthy that
the cloned EPEC LEE can confer AE activity upon E. coli
K-12 (34), whereas the cloned LEE from E. coli O157:H7
cannot (12), suggesting that there are differences in the control
of type III secretion between the strains. The involvement of
Efa1, Efa1, and ToxB in this process is the subject of ongoing
studies in our laboratory.
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